Chapel Hill startup with ties to UNC lands rights to drug offering hope to cystic fibrosis patients

Posted Oct 27, 2019
Path BioAnalytics (PBA), a precision medicine startup with ties to UNC, has scored the rights to a new drug therapy offering hope to cystic fibrosis (CF) patients with rare mutations. PBA is a graduate of Launch Chapel Hill, an accelerator program based in Chapel Hill, as well as the Kenan Flagler Business School program Startup UNC. (WRAL Tech Wire)

Related: Campus Connections

Tar Heels fans go bananas for Caleb Wilson before enjoying the Bananas show
Kenan Stadium was packed on a beautiful spring afternoon, and the atmosphere was bananas. And Tar Heels fans went bananas over one of their favorite...
Thu Apr 16, 2026

UNC makes 'new Ivies list for third consecutive year
UNC has made the Forbes list of “new Ivies” for the third straight year. Carolina is the only North Carolina institution on the list, which...
Wed Apr 15, 2026

Savannah Bananas put Bill Belichick to work during Chapel Hill stop
On Saturday, Bill Belichick took a break from spring practice at UNC to try his hand at coaching first base for the Savannah Bananas, who...
Sun Apr 12, 2026

Savannah Bananas bring excitement to Chapel Hill, small businesses look for a boost
Banana Ball is coming to the Triangle. The Savannah Bananas, the Harlem Globetrotters of baseball, take on the Texas Tailgaters at a sold-out Kenan Stadium...
Sun Apr 12, 2026